Key result
Primary aldosteronism screening and treatment must account for concurrent medication effects on lab results.
Provides a clinical overview of screening and treatment for primary aldosteronism, including medication effects on laboratory test results.
Answers are grounded in this paper and cite their sources.
Clinicians must adjust primary aldosteronism screening interpretation for concurrent medications; leaves open need for validated adjustment protocols.
This Clinical Insights provides an overview of screening for and treating primary aldosteronism, including information on how medications may affect laboratory test results.
No takes yet. Share an insight, caveat, or question.
Marogi et al. (2026) studied this question. Primary aldosteronism screening and treatment strategies must account for the potential effects of concurrent medications on laboratory test results.
Synapse has enriched 10 related papers. Consider them for comparative context: